Introducing
tile-based
radiation therapy
GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms.
Bioresorbable, conformable collagen tile
How it works
- Tiles are placed into the operative bed, covering the oncologically at-risk surfaces of the tumor cavity.1,2
- Tiles conform to the cavity and the hydrophilic collagen keeps it in place.1,2
- The number of tiles used is customized to each patient and determined by the size and location of tumor.1,2
- Implanted directly into the tumor cavity at the time of resection, GammaTile immediately starts delivering a targeted therapeutic dose to possible remaining tumor cells.1,2
- The collagen tile keeps the radiation source away from healthy tissue, reducing the risk of radiation side effects.1-10
- Favorable depth-dose profile optimizes local tumor control.1-10
- Uniform radiation-source spacing helps give a predictable, therapeutic radiation dose.1
Achieve local control
with optimized dosimetry.
50% of the therapeutic dose is delivered within the first 10 days after surgery, which helps prevent residual tumor cells from replicating.11
88% of the dose is delivered in ~30 days.10
Overtime, after the therapeutic dose has been delivered, the collagen is naturally resorbed by the body.2
The GammaTile Commitment Pledge
for recurrent brain tumors
If a GammaTile treatment of a recurrent brain tumor is canceled because intraoperative pathology reveals only necrotic tissue, we will update the invoice to reflect a $0 charge.*